Astrazeneca Vaccine
Recent Highlights
All Stories for Astrazeneca Vaccine
Delayed AstraZeneca doses will boost immunity, not compromise it: Study
•An interval of up to 45 weeks between the first and second dose of the AstraZeneca vaccine led to an enhanced immune response.
France hit by mystery ad campaign to discredit Pfizer's COVID-19 vaccine
•Influencers and YouTube personalities said they received an email from an apparently UK-based communications agency on behalf of a client with 'a colossal budget' who wanted to remain anonymous
AstraZeneca vaccine efficacy 6% less for 'Indian' COVID-19 variant compared to British one, finds UK study
•The study, conducted by Public Health England, also found that a double dose of COVID-19 vaccines is almost as effective against the fast-spreading 'Indian' variant
Adar Poonawalla's SII to invest over $300 million in UK
•The Serum Institute of India has been at the forefront of producing the lower-cost AstraZeneca coronavirus shot
COVID-19 vaccine: US to share upto 60 mn AstraZeneca doses with world, says White House
•The Biden administration has come pressure to share its vaccine supply with the world as India and Brazil experience devastating surges of the virus
J&J COVID-19 vaccine in limbo as countries, experts seek evidence for blood clotting issue
•Vaccination-related blood clots are raising alarm because they are at least three times more likely than experts expect of typical clots in the brain.
India will review claims of AstraZeneca vaccine causing blood clots in 'unusual' sites
Tech2 News Staff •There have been no reports of cases in India, authorities are still looking into claims as many countries have either stopped or limited the use of the vaccine.
COVID-19 side effects: What is thrombocytopenia, that's being linked to the AstraZeneca vaccine?
•Naturally occurring thrombocytopenia affects about one in 30,000 adults a year in the United States.
Amid blood clot scares, COVAX says it backs AstraZeneca's COVID-19 vaccine
•Covax's first wave intended to distribute some 238.2 mn doses to 142 countries, out of which 237 mn were AstraZeneca doses.
Joe Biden set to announce all US adults will be eligible for COVID-19 vaccination on 19 April
•The White House said Biden is shifting the deadline for full eligibility up from 2 May to 19 April after rapid progress in all 50 states in the vaccine rollouts